58.86
Eton Pharmaceuticals Inc stock is traded at $58.86, with a volume of 2.29M.
It is up +44.26% in the last 24 hours and up +56.92% over the past month.
Eton Pharmaceuticals Inc is a United States based specialty pharmaceutical company. The company is engaged in developing and commercializing pharmaceutical products to fulfill an unmet patient need. It has eight commercial rare disease products, INCRELEX, ALKINDI SPRINKLE, KHINDIVITM, GALZIN, PKU GOLIKE, Carglumic Acid, Betaine Anhydrous and Nitisinone. It also has five additional product candidates in late-stage development: ET-600, Amglidia, ET-700, ET-800 and ZENEO hydrocortisone autoinjector.
See More
Previous Close:
$40.80
Open:
$54.93
24h Volume:
2.29M
Relative Volume:
4.67
Market Cap:
$1.61B
Revenue:
$86.93M
Net Income/Loss:
$-1.48M
P/E Ratio:
-830.18
EPS:
-0.0709
Net Cash Flow:
$431.00K
1W Performance:
+31.97%
1M Performance:
+56.92%
6M Performance:
+244.82%
1Y Performance:
+252.46%
Eton Pharmaceuticals Inc Stock (ETON) Company Profile
Name
Eton Pharmaceuticals Inc
Sector
Phone
(847) 787-7361
Address
21925 W. FIELD PARKWAY, DEER PARK, IL
Compare ETON vs TAK, TEVA, HLN, ZTS, UTHR
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
|
ETON
Eton Pharmaceuticals Inc
|
58.86 | 1.14B | 86.93M | -1.48M | 431.00K | -0.0709 |
|
TAK
Takeda Pharmaceutical Co Adr
|
17.63 | 55.60B | 29.91B | 1.30B | 3.49B | 0.4056 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
36.77 | 42.81B | 17.53B | 1.58B | 444.18M | 1.3457 |
|
HLN
Haleon Plc Adr
|
9.70 | 43.16B | 14.54B | 2.22B | 2.58B | 0.4871 |
|
ZTS
Zoetis Inc
|
73.79 | 30.39B | 9.51B | 2.64B | 2.14B | 6.0361 |
|
UTHR
United Therapeutics Corp
|
499.73 | 21.95B | 3.17B | 1.29B | 1.01B | 27.09 |
Eton Pharmaceuticals Inc Stock (ETON) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jan-23-25 | Reiterated | H.C. Wainwright | Buy |
| Jan-10-25 | Initiated | B. Riley Securities | Buy |
| Jan-06-25 | Reiterated | H.C. Wainwright | Buy |
| Sep-04-24 | Resumed | H.C. Wainwright | Buy |
| May-06-24 | Initiated | Craig Hallum | Buy |
| Oct-14-21 | Resumed | B. Riley Securities | Buy |
| Jan-04-21 | Reiterated | H.C. Wainwright | Buy |
| Sep-20-19 | Initiated | B. Riley FBR | Buy |
| Jun-10-19 | Initiated | H.C. Wainwright | Buy |
View All
Eton Pharmaceuticals Inc Stock (ETON) Latest News
Eton Pharmaceuticals Stock Soars After Massive Q2 Beat And Guidance Hike - timothysykes.com
Responsive Playbooks and the ETON Inflection - Stock Traders Daily
Why Eton Pharmaceuticals Shares Are Trading Higher By 22%; Here Are 20 Stocks Moving Premarket - Sahm
Eton Pharmaceuticals Stock Soars After Huge Q2 Beat And Target Hikes - StocksToTrade
Eton Pharmaceuticals Soars After Blowout Q2 And Guidance Hike - timothysykes.com
Eton Pharmaceuticals Soars After Massive Q2 Beat And Guidance Hike - timothysykes.com
Eton Pharmaceuticals Soars As Q2 Beat Triggers Aggressive Target Hikes - StocksToTrade
86,249 Shares in Eton Pharmaceuticals, Inc. $ETON Acquired by Walleye Capital LLC - marketbeat.com
Is Eton Pharmaceuticals (ETON) Fully Priced On Strong Q2 Results And Raised Guidance? - Yahoo Finance
Why Eton Pharmaceuticals Is Top of the Class Today - The Motley Fool
Eton Pharmaceuticals Soars 39% After Earnings Beat and Upgraded Guidance - finance.biggo.com
This Analyst Believes Eton Pharma’s Raised Guidance Is ‘Conservative’ – ETON Stock Heads For Best Ever Day - Stocktwits
12 Health Care Stocks Moving In Friday's Intraday Session - Benzinga
ETON Stock Soars After Blowout Earnings And Guidance Hike - StocksToTrade
Eton Pharmaceuticals Stock Jumps 38% as Guidance Reset Tests Valuation - ts2.tech
Eton Pharmaceuticals: No Reason Pharma Can't Deliver More Great Earnings Like These - Seeking Alpha
Eton Pharmaceuticals stock hits all-time high at 55.07 USD By Investing.com - Investing.com South Africa
Why is Eton Pharmaceuticals stock surging today? By Investing.com - Investing.com Canada
Eton Pharmaceuticals stock hits all-time high at 55.07 USD - Investing.com
Eton Pharmaceuticals (NASDAQ:ETON) Sets New 1-Year High Following Earnings Beat - marketbeat.com
Eton Pharmaceutical (ETON) Stock Forum and Discussion - moomoo.com
Why is Eton Pharmaceuticals stock surging today? - Investing.com
Eton Pharmaceuticals, Inc. Q2 2026 Earnings Call Summary - Yahoo Finance
12 Health Care Stocks Moving In Friday's Pre-Market Session - Benzinga
B. Riley Adjusts Price Target on Eton Pharmaceuticals to $70 From $40, Maintains Buy Rating - marketscreener.com
Applied Industrial Technologies To Rally Around 12%? Here Are 10 Top Analyst Forecasts For Friday - benzinga.com
ETON SWOT Analysis: Financial Insights from 10-Q Filing - GuruFocus
Eton Pharmaceuticals Q2 2026 Earnings Call Transcript - marketbeat.com
Eton Pharmaceuticals Q2 Earnings Call Highlights - marketbeat.com
ETON PHARMACEUTICALS ($ETON) Releases Q2 2026 Earnings, Stock Rises - Quiver Quantitative
Earnings call transcript: Eton Pharmaceuticals tops Q2 2026 estimates, shares jump - Investing.com
Eton Pharmaceuticals, Inc. (ETON) Q2 Earnings and Revenues Beat Estimates - Yahoo Finance
Eton Pharmaceuticals Q2 Results: Revenue up 99%, EBITDA margin expands to 43% - scanx.trade
Eton Pharmaceuticals Q2 2026 Earnings Call: Complete Transcript - Benzinga
ETON: Record revenue, margin expansion, and portfolio growth drive raised 2026 guidance - TradingView
Eton Pharmaceuticals (NASDAQ:ETON) Releases Quarterly Earnings Results, Beats Expectations By $0.28 EPS - marketbeat.com
12 Health Care Stocks Moving In Thursday's After-Market Session - Benzinga
Eton Pharmaceuticals Inc reports results for the quarter ended June 30Earnings Summary - TradingView
Eton Pharmaceuticals soars 25% on earnings beat, raised guidance By Investing.com - Investing.com South Africa
After-Hours Movers: AMAT, DLO, GLOB, YSS, ETON - StreetInsider
Eton Pharmaceuticals soars 25% on earnings beat, raised guidance - Investing.com
After-Hours Movers: AMAT, DLO, GLOB, YSS, ETON By Investing.com - Investing.com Australia
Eton Pharmaceuticals Q2 Adjusted Earnings, Revenue Rise - marketscreener.com
Eton Pharmaceuticals (NASDAQ: ETON) swings to H1 2026 profit on revenue jump - Stock Titan
Eton Pharmaceuticals posts Q2 2026 revenue $37.6M, GAAP EPS $0.35 and raises 2026 revenue outlook - TradingView
Eton Pharmaceuticals Reports Second Quarter 2026 Financial Results - The Manila Times
BRIEF-Eton Pharmaceuticals Q2 Net Income USD 11.578 Million - TradingView
Eton Now Expects 2026 Revenue to Exceed $145M After Q2 - Stock Titan
Eton Pharmaceuticals earnings ahead: Profitability in focus By Investing.com - Investing.com Nigeria
Eton Pharmaceuticals earnings ahead: Profitability in focus - Investing.com
Equities Analysts Issue Forecasts for ETON FY2027 Earnings - marketbeat.com
Eton Pharmaceuticals Inc Stock (ETON) Financials Data
Revenue
Net Income
Cash Flow
EPS
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):